People with type 2 diabetes also have a much higher risk of other 57 diseases, including cancer, kidney disease, and neurological disorders.
The discovery came in the most comprehensive medical research to date .
Millions of people worldwide suffer from diabetes, which is linked to overweight or distance from physical activity or a family history of type 2 diabetes.
Diabetes increases the risk of various complications and keeping this in mind, experts from the University of Cambridge in the UK conducted an in-depth examination.
The largest study of middle-aged people with or without diabetes found that the condition increased the risk of developing 57 other long-term illnesses.
On average, diabetics experience age-related medical problems 5 years earlier than healthy people.
Experts say the results are shocking and highlight the urgent need to protect people from developing type 2 diabetes.
The study examined data from 3 million people in the UK Biobank and doctors’ records examining 116 diseases that are common in middle-aged people.
The results found that 57 out of 116 diabetics had a higher risk of developing diabetes, with a 9% increased risk of cancer.
Similarly, patients with type 2 diabetes have a 5.2-fold increased risk of developing late-stage kidney disease, a 4.4-fold increased risk of liver cancer, and a 3.2-fold increased risk of muscle loss.
When it comes to blood circulation problems, 23 out of 31 patients with type 2 diabetes have a very high risk.
The study linked type 2 diabetes to the risk of poor health in all 11 health categories: 2.6 times the risk of mental and neurological problems, 2.3 times the risk of vision problems, 1.9 times the risk of digestive problems and mental health. The risk of disease is 1.8 times higher.
The study focused on people over the age of 30, and experts found that people diagnosed with type 2 diabetes before the age of 50 may be at higher risk.
The researchers said that the results show that prevention or slowing down the spread of diabetes in middle age is essential for the prevention of life-threatening diseases.
The results of this study have not yet been published in any medical journal but were presented at the Diabetes UK Professional Conference.